HeyJaredNucleate Singapore Pulse
Singapore's premier podcast on the biotech ecosystem.The show notes and transcripts can be found on nucleatesingapore.substack.com.
- Indexed episodes, last 90 days
- 3
- Latest publication
- Sep 19, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 19, 2026
Latest episodes
Reprogramming cells with AI for improved biologics manufacturing with Jie Sun of ChemT Biotech (opens the original)
Read excerpt
Jie Sun, Co-founder and CEO of ChemT Biotechnology, joins the show to discuss how artificial intelligence, virtual cell models, and small-molecule interventions could reshape biologics manufacturing. Drawing on a career spanning healthcare consulting, pharmaceutical project management, regulated healthcare AI, and entrepreneurship, Jie shares how her experience across Southeast Asia and the United States shaped her approach to identifying valuable problems and building globally relevant companie
Revealing chemical dark matter to generate new medicines with Dr. Damien Keogh of BluMaiden Biosciences (opens the original)
Read excerpt
Dr. Damien Keogh, Founder and CEO of BluMaiden Biosciences, joins the show to discuss how artificial intelligence, computational biology, and entrepreneurship are transforming drug discovery. Drawing on a career that spans molecular microbiology, academia, venture capital, and biotech company building, Damien shares his journey from studying microbial biology in Ireland to founding a Singapore-based biotech company developing novel therapeutics from the human microbiome. In this episode, Damien
Charting Singapore's Biotech Pipeline with Dr. Katherine Wang of A*STAR's STDR (opens the original)
Read excerpt
Dr. Katherine Wang, Deputy Director of the Biomedical Research Council and lead of the Singapore Therapeutics Development Review (STDR), joins the show to unpack what it really takes to move a scientific discovery from the lab bench to a viable biotech company. Drawing on a career that spans a PhD at NYU, tech transfer, program building at Duke-NUS, and now national drug-discovery strategy at A*STAR, Katherine explains why Singapore's researchers excel at science but stumble at commercialization
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Not enough subject data for this period yet.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.